Drugs / Western Equine Encephalitis Vaccine
Western Equine Encephalitis Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01159561 | Feb 2010 → Aug 2011 | viral infectious disease | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Western Equine Encephalitis Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01159561 ↗ |
| Known as | WEE TSI-GSD 210 | “An experimental inactivated Western Equine Encephalitis Vaccine (WEEV; WEE TSI-GSD 210) has been used under an IND (investigational New Drug) protocol at the United States Army...” PMID 33240257 ↗ Nov 2020 |
| Known as | WEEV | “An experimental inactivated Western Equine Encephalitis Vaccine (WEEV; WEE TSI-GSD 210) has been used under an IND (investigational New Drug) protocol at the United States Army...” PMID 33240257 ↗ Nov 2020 |
| Modality | Vaccine | “An experimental inactivated Western Equine Encephalitis Vaccine (WEEV; WEE TSI-GSD 210) has been used under an IND (investigational New Drug) protocol at the United States Army...” PMID 33240257 ↗ Nov 2020 |
| Route | Subcutaneous | “administered in 0.5 mL doses subcutaneously in the upper outer aspect of the triceps” NCT01159561 ↗ |